High STAT3 Expression Linked to Poor Prognosis in Lymphoma
Author Information
Author(s): ZL Wu, YQ Song, YF Shi, Zhu J
Primary Institution: Peking University School of Oncology, Beijing Cancer Hospital & Institute
Hypothesis
The study investigates the expression and prognostic value of STAT3 in diffuse large B-cell lymphoma (DLBCL).
Conclusion
High nuclear expression of STAT3 is correlated with poor overall survival in DLBCL patients.
Supporting Evidence
- Strong nuclear staining of STAT3 was observed in 25.7% of cases.
- High STAT3 expression was correlated with poor overall survival (OS) with a p-value of 0.005.
- The study included 74 DLBCL patients from 2001 to 2007.
Takeaway
This study found that patients with high levels of a protein called STAT3 in their lymphoma cells tend to have worse outcomes.
Methodology
The study reviewed 74 DLBCL patients and examined STAT3 expression in tumor tissues using immunohistochemistry.
Limitations
The study's findings may be limited by the small sample size and the lack of statistical significance in some comparisons.
Participant Demographics
30 male and 44 female patients, with 55 patients younger than 60 years old.
Statistical Information
P-Value
0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website